InvestorsHub Logo
Followers 19
Posts 1098
Boards Moderated 0
Alias Born 03/27/2013

Re: None

Monday, 10/16/2017 11:11:24 AM

Monday, October 16, 2017 11:11:24 AM

Post# of 403248
"We've actively engaged with multiple large pharmas, who have expressed an interest in Brilacidin inflammatory bowel disease. The pharma industry is quite interested in pursuing novel IBD therapies one of the more active therapeutic areas when it comes to dealmaking."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News